When more expensive medicine is better
The theory behind the health reform law is that you can deliver better care at lower cost. Support for that idea comes from a robust body of research—most prominently the Dartmouth Atlas project. But sometimes, more expensive care is also better care. That's what a team of healthcare economists have found in a new NBER paper, which looked at Medicare patients in New York. It found that, all other things being equal, those treated in higher-spending hospitals had mortality rates 20 to 30 percent lower than those treated in low-cost facilities. Those findings, in some ways, contradict the Dartmouth Atlas research, which has suggested that more can be less.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- Handshaking Spreads Germs. Get Over It.
- IOM Identifies GME Problems, Calls for Finance Changes
- Healthcare Costs Start With What We Eat
- Revenue Cycles Get a Boost from Simple JPEG Files
- Hospitals Likely to Outsource ICD-10 at Launch
- Anatomy of 3 Health System Rebranding Efforts